228 related articles for article (PubMed ID: 9810784)
21. Erythropoietin, interleukin-3, interleukin-11, and GM-CSF in posttransplant erythrocytosis treated with enalapril.
Hu RH; Lee PH; Lee CJ
Transplant Proc; 1996 Jun; 28(3):1545-7. PubMed ID: 8658779
[No Abstract] [Full Text] [Related]
22. Preventive effect of enalapril on erythrocytosis after renal transplantation.
Rhee SR; Park SK; Kang SK; Kim SH; Cho BH; Kim JH
Transplant Proc; 1996 Jun; 28(3):1555-6. PubMed ID: 8658783
[No Abstract] [Full Text] [Related]
23. Use of aminophylline and enalapril in posttransplant polycythemia.
Mazzali M; Filho GA
Transplantation; 1998 Jun; 65(11):1461-4. PubMed ID: 9645803
[TBL] [Abstract][Full Text] [Related]
24. New insights and treatment in posttransplant polycythemia (erythrocytosis) of renal recipients.
Sauron C; Berthoux P; Berthoux F; Alamartine E; Diab N; Broyet C; Hacini J
Transplant Proc; 1993 Feb; 25(1 Pt 2):1032-3. PubMed ID: 8382847
[No Abstract] [Full Text] [Related]
25. A randomized placebo-controlled study of enalapril in the treatment of erythrocytosis after renal transplantation.
Beckingham IJ; Woodrow G; Hinwood M; Rigg KM; Morgan AG; Burden RP; Broughton-Pipkin F
Nephrol Dial Transplant; 1995 Dec; 10(12):2316-20. PubMed ID: 8808232
[TBL] [Abstract][Full Text] [Related]
26. Enalapril treatment of posttransplant erythrocytosis: efficacy independent of circulating erythropoietin levels.
Perazella M; McPhedran P; Kliger A; Lorber M; Levy E; Bia MJ
Am J Kidney Dis; 1995 Sep; 26(3):495-500. PubMed ID: 7645558
[TBL] [Abstract][Full Text] [Related]
27. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
[TBL] [Abstract][Full Text] [Related]
28. Factors predisposing to post-renal transplant erythrocytosis: a retrospective study.
Charfeddine K; Zaghdane S; Yaich S; Hakim A; Hachicha J
Saudi J Kidney Dis Transpl; 2008 May; 19(3):371-7. PubMed ID: 18445895
[TBL] [Abstract][Full Text] [Related]
29. The beneficial effect of enalapril on erythrocytosis after renal transplantation.
Conlon PJ; Farrell J; Donohoe J; Walshe JJ
Transplantation; 1993 Jul; 56(1):217-9. PubMed ID: 8333046
[No Abstract] [Full Text] [Related]
30. Posttransplant erythrocytosis in renal transplant recipients at Jeddah Kidney Center, Kingdom of Saudi Arabia.
Basri N; Gendo MZ; Haider R; Abdullah KA; Hassan A; Shaheen FA
Exp Clin Transplant; 2007 Jun; 5(1):607-9. PubMed ID: 17617052
[TBL] [Abstract][Full Text] [Related]
31. Correction of post-renal transplant erythrocytosis by enalapril.
Rostaing L; Boisseau M; Huyn A; Durand D
Scand J Urol Nephrol; 1995 Dec; 29(4):399-406. PubMed ID: 8719356
[TBL] [Abstract][Full Text] [Related]
32. Treatment of postrenal transplant erythrocytosis. Long-term efficacy and safety of angiotensin-converting enzyme inhibitors.
MacGregor MS; Rowe PA; Watson MA; Rodger RS; Junor BJ; Briggs JD
Nephron; 1996; 74(3):517-21. PubMed ID: 8938674
[TBL] [Abstract][Full Text] [Related]
33. Posttransplant erythrocytosis: a model for the investigation of the pharmacological control of renal erythropoietin production?
Gleiter CH
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):489-92. PubMed ID: 8937931
[TBL] [Abstract][Full Text] [Related]
34. Long term effects of ACE inhibitors on the erythrocytosis in renal transplant recipients.
Lal SM; Trivedi HS; Ross G
Int J Artif Organs; 1995 Jan; 18(1):13-6. PubMed ID: 7607751
[TBL] [Abstract][Full Text] [Related]
35. Anemia and angiotensin-converting enzyme inhibition in renal transplant recipients.
Sizeland PC; Bailey RR; Lynn KL; Robson RA
J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S117-9. PubMed ID: 1708009
[TBL] [Abstract][Full Text] [Related]
36. Treatment of post-renal-transplant erythrosis: ACE inhibitors or theophylline?
Ben Hmida M; Hachicha J; Jarraya F; Kharrat M; Jarraya A
Transplant Proc; 1995 Oct; 27(5):2720-1. PubMed ID: 7482889
[No Abstract] [Full Text] [Related]
37. Angiotensin converting enzyme gene polymorphism and development of post-transplant erythrocytosis.
Yildiz A; Yazici H; Cine N; Kazancioglu R; Akkaya V; Sever MS; Ark E; Erginel-Unaltuna N
J Nephrol; 2003; 16(3):399-403. PubMed ID: 12832741
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the effects of enalapril and losartan on posttransplantation erythrocytosis in renal transplant recipients: prospective randomized study.
Yildiz A; Cine N; Akkaya V; Sahin S; Ismailoğlu V; Türk S; Bozfakioğlu S; Sever MS
Transplantation; 2001 Aug; 72(3):542-4. PubMed ID: 11502994
[TBL] [Abstract][Full Text] [Related]
39. Erythrocytosis after renal transplant: study of erythroid progenitors and response to enalapril.
Rostaing L; Demur C; Huyn A; Durand D; Lloveras JJ; Suc JM
Transplant Proc; 1994 Feb; 26(1):280-1. PubMed ID: 8108980
[No Abstract] [Full Text] [Related]
40. Early posttransplant erythrocytosis in renal allograft recipients.
Prakash J; Singh S; Behur SK; Ghosh B; Sharatchandra LK; Dwivedi US
J Assoc Physicians India; 2010 Sep; 58():574-6. PubMed ID: 21391381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
